investorscraft@gmail.com

Intrinsic ValueTransAct Technologies Incorporated (TACT)

Previous Close$3.68
Intrinsic Value
Upside potential
Previous Close
$3.68

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

TransAct Technologies Incorporated operates in the technology sector, specializing in the design, manufacture, and distribution of transaction-based printers and related products. The company primarily serves the food service, casino and gaming, and point-of-sale (POS) industries, offering hardware and software solutions that facilitate efficient transaction processing. Its core revenue model is driven by hardware sales, recurring service contracts, and consumables, positioning it as a niche player in specialized vertical markets. TransAct’s market position is bolstered by its deep industry expertise and long-standing relationships with key customers, though it faces competition from larger, diversified technology firms. The company’s focus on high-margin, industry-specific solutions provides a defensible niche, but its growth is constrained by the relatively small addressable markets it serves. TransAct’s ability to innovate and adapt to evolving customer needs will be critical in maintaining its competitive edge.

Revenue Profitability And Efficiency

TransAct reported revenue of $43.4 million for the fiscal year ending December 31, 2024, but recorded a net loss of $9.9 million, reflecting operational challenges. The diluted EPS of -$0.99 underscores profitability pressures, likely due to elevated costs or competitive pricing dynamics. Operating cash flow of $1.9 million suggests some ability to generate liquidity, though capital expenditures of $0.3 million indicate limited reinvestment in growth initiatives.

Earnings Power And Capital Efficiency

The company’s negative net income and EPS highlight weakened earnings power, likely impacted by margin compression or one-time expenses. With modest operating cash flow relative to revenue, capital efficiency appears strained. The balance between sustaining operations and funding growth remains a critical challenge, as evidenced by the limited capex and ongoing profitability concerns.

Balance Sheet And Financial Health

TransAct maintains a solid liquidity position with $14.4 million in cash and equivalents, against total debt of $4.2 million, suggesting a manageable leverage profile. The absence of dividends aligns with its current focus on preserving capital. However, the net loss raises questions about long-term financial sustainability if profitability does not improve.

Growth Trends And Dividend Policy

Revenue trends and profitability metrics indicate stagnant or declining performance, with no dividend payments reflecting a conservative capital allocation strategy. The company’s growth prospects hinge on its ability to expand its product offerings or penetrate new markets, though current financials do not signal near-term acceleration.

Valuation And Market Expectations

The market likely views TransAct as a speculative play given its profitability challenges and niche focus. Valuation metrics would depend on turnaround potential, but the current EPS and cash flow figures suggest limited investor optimism without significant operational improvements.

Strategic Advantages And Outlook

TransAct’s deep industry relationships and specialized product portfolio provide some strategic advantages, but its outlook remains uncertain due to profitability pressures. Success will depend on cost management, innovation, and potential market expansion, though execution risks persist in a competitive landscape.

Sources

Company filings (10-K), CIK 0001017303

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount